Why this matters: Three distinct ORTEX signals are firing on CTRN simultaneously. Options traders have gone all-in on the bull side. Short sellers are adding exposure even as the stock climbs. The lending market remains relaxed. Together, these signals paint a picture of a stock under genuine tug-of-war tension.
The put-call ratio for Citi Trends hit zero on August 24. Not near zero — exactly zero. No puts traded relative to calls.
The z-score on that reading is -3.76, nearly four standard deviations below the 20-day mean PCR of 0.003. The 52-week high PCR was 0.48, so this is a complete reversal of the options posture.
The stock has risen 18% over the past month. Options positioning suggests the buyers aren't hedging that move — they're pressing it.
SI stands at 11% of free float as of August 24. That's a high reading for an apparel retailer. It rose 11.7% over the past week alone, even as the stock gained 3.7% in a single session.
Days to cover sit at 7.45 per the latest FINRA data — a meaningful cushion for short sellers, but also a meaningful squeeze risk if the stock keeps climbing.
The ORTEX short score is 58.6, hovering near its recent range of 56–61. No dramatic move there, but the score reflects elevated structural short pressure.
Cost to borrow jumped 60% over the past week to 0.53%. That sounds alarming. It isn't — yet. At 0.53%, CTB remains near historic lows for this name. The one-month change is just 4%.
Availability sits at 659% — roughly six-and-a-half shares available to borrow for every one already lent out. The lending pool is not under stress. That said, availability has tightened 19% over the past week, worth watching if short interest keeps building.
Pleasant Lake Partners holds 22.5% of shares and trimmed 750,000 shares as of June 30. Divisadero Street added 211,000 shares in the same period. Goldman Sachs added 82,000. The holder base is actively repositioning.
DA Davidson raised its price target to $73 in June (now below the current $74.35 price) and maintains a Buy. The analyst consensus target is $77, implying modest upside from current levels.
What to watch: Whether the PCR remains at zero into next week, and whether the CTB and availability trends continue tightening as short sellers add against the options-driven bullish sentiment. Next earnings are not until December 1.
See the live data behind this article on ORTEX.
Open CTRN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
